Author:
Bastos-Pereira Amanda Leite,Lugarini Daiana,de Oliveira-Christoff Adriana,Ávila Thiago Vinicius,Teixeira Simone,Pires Amanda do Rocio Andrade,Muscará Marcelo Nicolás,Cadena Sílvia Maria Suter Correia,Donatti Lucélia,da Silva de Assis Helena Cristina,Acco Alexandra
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference41 articles.
1. Gasparini G, Longo R, Sarmiento R, Morabito A (2003) Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol 4:605–615
2. Grösh S, Maier TJ, Schiffmann S, Geisslinger G (2006) Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 98(11):736–747
3. Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV (2000) Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, Celecoxib, administered during different stages of carcinogenesis. Cancer Res 60:293–297
4. Amir M, Agarwal HK (2005) Role of COX-2 selective inhibitors for prevention and treatment of cancer. Pharmazie 60(8):563–570
5. Cianchi F, Cortesini C, Fantappiè O, Messerini L, Sardi I, Lasagna N, Perna F, Fabbroni V, Di Felice A, Perigli G, Mazzanti R, Masini E (2004) Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clin Cancer Res 10:2694–2704
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献